SCLCYAP1TIME:

Yu-Qing Chen1,2,3,4, Jia-Xiong Tan1,2,3,4, Ling-Ling Gao5,4

  • 1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.

概括

在小细胞肺癌 (SCLC) 中YAP1表达与预后不佳和抑制性瘤免疫微环境 (TIME) 相相关. 在接受基于阿特佐利祖马布的化疗的患者中,高YAP1表明无进展生存率较差.